Zurueck zur Suche

Reporte zur Charge U033041

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
1Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
GA 2 IA 1 NJ 1 OH 1 VA 1

VAERS 2608335

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U033041

kritisch
Staat
IA
Alter
1,0
Geschlecht
M
Eingang
03.04.2023
Impfdatum
21.12.2022
Beginn
24.12.2022
Tage bis Beginn
3,0
Dosis
UNK
Route/Site
IM / RL
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Febrile convulsion

Symptomtext

Febrile seizure the following day. Died 3 days later of unknown causes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Recent febrile seizure the day after receiving vaccines.
Vorgeschichte
None
Andere Medikamente
None
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2567337

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (OTHER) · Charge U033041

mild
Staat
NJ
Alter
5,0
Geschlecht
F
Eingang
25.01.2023
Impfdatum
18.01.2023
Beginn
19.01.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site rash No reaction on previous exposure to drug Rash Skin lesion

Symptomtext

Family had a bilingual staff member spoke with mom. Mom called HD on 1.23.23 & stated that daughter received vaccines listed above on 1.18.23 at HD & following day daughter had developed a rash on left upper arm that was distributed to part of body. Mom stated there were also some small lesions on the body. Per mom no additional symptoms were noted & no one in the home had any similar symptoms. Per mom started benadryl for 3 days in which "lesions" improved. After stopping Benadryl, the "lesions" reappeared although smaller. Mom states rash is now resolving. Patient has received previous vaccinations including 1st dose of MMR and previous doses of polio and DTaP without any type of reaction in past. This was patient's first time receiving Kinrix. Patient is without insurance and was not evaluated by doctor. Previously referred to social work on 1.18.23 & several low cost clinics in area were provided to mom for follow-up on day of call.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site rash
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKDA, No Known Food Allergies
Vorherige Impfungen
-

VAERS 2533236

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U033041

mild
Staat
OH
Alter
1,0
Geschlecht
F
Eingang
15.12.2022
Impfdatum
02.12.2022
Beginn
13.12.2022
Tage bis Beginn
11,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Decreased appetite Dermatitis diaper Diarrhoea Influenza virus test Laboratory test Pyrexia Rash morbilliform SARS-CoV-2 test

Symptomtext

Morbilliform rash began on 12.13.2022. Fever started on 12.12.2022, diarrhea, decreased appetite, diaper rash

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
Flu, COVID and respiratory panels sent
Aktuelle Erkrankungen
NOne
Vorgeschichte
Tricuspid valve regurgitation, Patent foramen ovale,
Andere Medikamente
None
Allergien
NKDA, no known allergies
Vorherige Impfungen
-

VAERS 2709018

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U033041

gering
Staat
GA
Alter
-
Geschlecht
U
Eingang
03.11.2023
Impfdatum
26.10.2023
Beginn
26.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Office manager calling to report that a dose of MMR II was administered 5 days after its labeled expiration date. Administration date: 10/26/2023, expiration date: 10/21/2023. Caller confirmed the product has never experienced a temperature excursion; This spontaneous report was received from the office manager refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 26-OCT-2023, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, rHA (recombinant Human albumin) (M-M-R II) lot # U033041, expiration date:21-OCT-2023, 0.5 milliliter (route of administration and anatomical location were not reported) for prophylaxis. It was reported that a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, rHA (recombinant Human albumin) (M-M-R II) was administered 5 days after its labeled expiration date. Caller confirmed the product has never experienced a temperature excursion (expired product administered).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2707889

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U033041

gering
Staat
GA
Alter
-
Geschlecht
U
Eingang
01.11.2023
Impfdatum
23.10.2023
Beginn
23.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No side effects reported; HCP calling to report AE for expired dose of MMRII that was administered to a patient on 23OCT2023.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 23-OCT-2023, the patient was vaccinated with an expired dose of measles, mumps, and rubella (WISTAR RA 27-3) virus vaccine, live (M-M-R II) injection, therapy type: rHA, lot #U033041, expiration date: 21-OCT-2023, administered for prophylaxis (strength, and route of administration were not provided) (Expired product administered). The vaccine did not have any previous temperature excursions. No side effects reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2490993

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U033041

gering
Staat
VA
Alter
6,0
Geschlecht
M
Eingang
26.10.2022
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect product formulation administered No adverse event

Symptomtext

Nurse gave 5-11 BIV as primary series as current recommendation state 5-11 BIV for booster dose only. Patient observed for 15 min post exposure. Discharged WNL.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Cough
Vorgeschichte
none
Andere Medikamente
-
Allergien
None
Vorherige Impfungen
-